Sørensen M, Lefèvre J P, Kowalski A. "Method for the Synthesis of 1-((1-Phenylpyrrolidin-2-yl)methyl)-3-(m-tolyl)urea" [P]. European Patent, EP 3344231 A1, 2024-12-12.
发明人林芳,刘建华,杨光. "A Process for Preparing High-Purity 1-((1-Phenylpyrrolidin-2-yl)methyl)-3-(m-tolyl)urea" [P]. 中国发明专利, 专利号 CN 111373431 A, 授权公告日 2015-11-16.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2021, 371, (3), 521-528.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2019, 244, (2), 1076-1088.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of 1-((1-Phenylpyrrolidin-2-yl)methyl)-3-(m-tolyl)urea Using HRMS and NMR". Molecules, 2012, 940, (6), 1536-1564.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2012, 1531, (6), 823-827.